Disability Progression in Multiple Sclerosis: Patient and Clinician Perspectives on Care
A patient and clinicians provide essential perspectives on multiple sclerosis (MS) care. Join us for an in-depth discussion on disability progression in MS.
Related Articles
SGLT2 Inhibitors: From Glucose-Lowering to Cardio Protection
Initially used for blood glucose control, the medications reduce cardiovascular events and mitigate heart failure hospitalization, regardless of diabetes status.
Small Earwax Sample, Big Diagnostic Clues
A novel cerumen assay called the cerumenogram differentiates healthy and cancerous profiles with remarkable accuracy from tiny wax samples.
AI Meets Frailty: Rethinking Hematology in Older Patients
Hematologists treating older patients face complex challenges, from remembering drug interactions to tailoring individualized treatment pathways. Can AI help?
Regulatory Challenges for Nurse Practitioners and Physician Assistants: Changes Are Constant
Practitioners in each profession detail the speed of regulatory challenges and changes, emphasize the importance of keeping up, and offer advice on how to do…
Probiotics, Prebiotics Tied to Decreased Depression, Anxiety
The use vs nonuse of probiotics and prebiotics, alone or combined, are linked to a greater decrease in depression and anxiety symptoms, new research shows.
Nurse Practitioner Identity and Recognition Key to Success
NPs are increasingly important to the US healthcare system, but getting the respect and recognition that should come with that role is still a challenge.
AI and Home Dialysis: From Prediction to Personalization
Artificial intelligence and telemedicine are transforming dialysis care, improving predictions, expanding access, and enabling patient-centered home therapies.
Landmark 20-Year Study Reshapes Understanding of PTSD
A 20-year study — the longest of its kind — shows PTSD symptoms can persist for decades, challenging recovery timelines and offering insights to guide…
Popular Diabetes Drug Helps Treat Progressive Liver Disease
Dapagliflozin, a SGLT2 inhibitor used for type 2 diabetes, alleviates steatohepatitis and fibrosis in patients with progressive liver disease, a recent clinical trial shows.
Medscape
Hereditary Angioedema Headlines: Early Intervention Strategies for Managing Attacks and Improving Patient Outcomes